The final version of EU GMP Annex 1 is an opportunity for industry to apply solutions that emphasize advanced technologies and allow Pharma companies to speed up their processes, reduce human error to ensure that final products are protected from microbial, particulate and pyrogen contamination and are safe for patients. This webinar will discuss the requirements that may impact your organization.
Speaker: Mark Mitchell, Principal Consultant at Pharmatech Associates
Visit our website: pharmatechassociates.com/
7 авг 2024
